short stories

TMCx company recognized internationally, Cannon acquires Houston fintech startup, and more innovation news

From startup pitch competitions seeking applications to Houston startups with big news, here are the latest short stories of Houston innovation. Photo courtesy TMC Innovation

Houston's innovation ecosystem has been booming with news fresh out of the gate for 2021, and it's likely some might have fallen through the cracks.

For this roundup of short stories within Houston innovation, a TMCx startup gets called out by Time Magazine, pitch competitions seek entries for thousands of dollars of investment prizes, and more.

The Cannon closes its acquisition of LetsLaunch

The Cannon has announced that it has has acquired Houston-based crowdfunding startup LetsLaunch. Photo courtesy of The Cannon

Last summer, The Cannon, a Houston startup development organization with a network of coworking hubs, announced its plans to acquire a Houston fintech startup, LetsLaunch. The online investment platform allows for smaller investments from non-accredited investors and has been connected with The Cannon in the past, and the two entities have even had a partnership arrangement.

As of last week, The Cannon has officially acquired LetsLaunch. The deal allows Cannon member companies access to a new fundraising option.

"The Cannon and LetsLaunch have a shared vision for enabling and optimizing the innovation ecosystem," says Jon Lambert, CEO of The Cannon, in a news release. "LetsLaunch has passionately developed a technology platform that will deliver significant value to the entrepreneurial community by bringing together start-ups and investors of all kinds. By integrating the LetsLaunch platform into The Cannon's digital offerings, we will enhance the fundraising and strategic connection value we offer to our innovation community."

TMCx startup named to Time's top inventions

A U.K. company that recently participated in TMCx has been honored by Time Magazine. Photo courtesy of TMC

Health tech startup, Virti, which recently completed the Texas Medical Center's startup accelerator, was honored among Time Magazine's top inventions of 2020 in the augmented and virtual reality category.

Virti's artificial intelligence provides its users with instant feedback on training — and, in light of the pandemic, event indicates the right way to wear personal protective equipment, administer treatment, or ventilate a patient. According to a press release, this technology — as compared to traditional face-to-face training — has proven a 230 percent increase in knowledge gain and a 52 percent reduction in skill-fade post-training.

In the United Kingdom, where Virti was founded, the technology has been used to train 100,000 NHS staff, according to the release.

"This achievement rounds off what has been a very exciting year for Virti with significant growth in the United States and internationally building on successful partnerships such as the UK TMC BioBridge through the UK's Department for International Trade (DIT)," says Dr. Alex Young, Virti founder and CEO, in the press release.

Virti has US offices in Houston and the West Coast.

"The evidence is clear — immersive training that simulates real-world situations is more conducive to long-term memory and recall," says Lance Black, associate director of TMC Innovation, in the release. "Virti has unlocked how to provide high quality education to care teams to better prepare them for any situation as evidenced by their rapid adoption within the Texas Medical Center. The recognition by Time further demonstrates that Virti is ushering us into a new era of education and training, one that blurs the line between reality and fiction."

HX Venture Fund calls for Houston startups for pitch competition

The HX Venture Fund is looking for startups to pitch at a new event. Photo via Getty Images

The HX Venture Fund is preparing for two-day summit — called Venture Houston — next month and is looking for local startups to pitch in the conference's pitch competition.

According to the website, HXVF is looking for all pre-seed through series B companies interested in venture backing, and headquartered in Houston and the Gulf Coast Region. The competition has $1.65 million in investment prizes on the line from investors like Fitz Gate Ventures, The Artemis Fund, Montrose Lane (née Cottonwood Venture Partners), Mercury Fund, and more.

The application for the pitch competition is due January 15 and can be submitted online. If selected, startups will pitch during the February 4-5 event. To register for the virtual event, click here.

Validere announces partnership with California company to focus on ESG

Validere has a new partnership. Photo courtesy of Validere

Canadian energy supply chain software company, Validere, which has a growing presence in Houston, has announced a new strategic partnership with California-based Xpansiv. According to a news release, the partnership "enables the registration and transaction of digitized commodity products with embedded Environmental, Social, and Governance (ESG) attributes that support integration of ESG data into commodity markets."

Validere works with its oil and gas customers to provide tech solutions to connect, track, and audit data, allowing for transparency and optimization. This technology also allows corporations to prioritize ESG initiatives — something Nicole Rogers, senior vice president at Validere, recently joined the Houston Innovators Podcast to discuss.

"Validere is proud to partner with Xpansiv to provide another pathway to value creation for our customers," Validere CEO Nouman Ahmad says in a news release. "The initiative supports our defining belief that accurate, accessible product-quality data can be used to create multiple forms of value."

Apply now: Capital Factory to host pitch competition for Black entrepreneurs

Capital Factory is hosting its annual Black in Tech event. Getty Images

For the third year, Capital Factory, a Texas-wide startup development organization, is seeking Black entrepreneurs to pitch for a $100,000 prize. The competition, which will be on February 16 during Capital Factory's Black in Tech Summit, will have five technology startup finalists that will be judged by a panel of successful entrepreneurs, industry leaders and mentors. One startup will take home a $100,000 prize.

The application deadline is January 22, and any startups with a Black founder can apply online. For more information on the summit and the competition, click here.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted